Yue Luo

Chengdu Blood Center

H指数:20

被引数:1,748

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A novel B variant (c.2T>C) affecting the start codon of the ABO gene is associated with weak B phenotype

一种影响<i>ABO</i>基因起始密码子的新型<i>B</i>等位基因（c.2T>C）与弱B表型相关

Transfusion

IF2

2026-09-300

PRE

An innovative hippocampal-sparing whole-brain radiotherapy planning approach via the Halcyon system: achieving lower hippocampal doses

一种通过Halcyon系统实现的保护海马体的全脑放射治疗计划方法：实现较低的海马体剂量

Frontiers in Oncology

IF3.3

2025-09-020

Exposure of perfluorohexane sulfonate alters platelet homeostasis: From epidemiological evidence to mechanistic insights

全氟己烷磺酸暴露改变了血小板稳态：从流行病学证据到机制见解

Ecotoxicology and Environmental Safety

IF6.1

2025-08-120

PRE

Design of a novel multiband terahertz metamaterial absorber using a deep learning framework

基于深度学习框架的新型多波段太赫兹超材料吸波器设计

ENGINEERING APPLICATIONS OF ARTIFICIAL INTELLIGENCE

IF8

2025-07-010

PRE

Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway

Aurora激酶A通过Wnt/β-连环蛋白信号通路促进肝星状细胞活化及肝纤维化

FRONTIERS IN ONCOLOGY

IF3.3

2025-01-060

OAAI

Accelerated High-Index Saddle Dynamics Method for Searching High-Index Saddle Points

加速高阶鞍点动力学方法用于搜索高阶鞍点

JOURNAL OF SCIENTIFIC COMPUTING

IF3.3

2025-01-031

Safety and efficacy of ifebemtinib (IN10018) combined with D-1553 in solid tumors with KRAS G12C mutation: Results from a phase Ib/II study

ifetrobanib (IN10018)联合D-1553治疗KRAS G12C突变实体瘤的安全性与有效性：一项 Ib/II 期研究的结果

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

The mutation of Japanese encephalitis virus envelope protein residue 389 attenuates viral neuroinvasiveness

VIROLOGY JOURNAL

IF3.8

2024-06-052

OAAI

Factors associated with the SARS-CoV-2 immunoglobulin-G titer levels in convalescent whole-blood donors: a Chinese cross-sectional study

SCIENTIFIC REPORTS

IF3.9

2024-03-130

OAAI

Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China (vol 14, 1191479, 2023)

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-11-070

OAAI

Targeting of Annexin A1 in Tumor-associated Macrophages as a therapeutic strategy for hepatocellular carcinoma

BIOCHEMICAL PHARMACOLOGY

IF5.6

2023-07-018

OAAI

Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-06-143

OAAI

Giant Nonlinear Optical Response via Coherent Stacking of In-Plane Ferroelectric Layers

通过平面内铁电层的相干堆叠产生巨大的非线性光学响应

ADVANCED MATERIALS

IF26.8

2023-05-1215

STIM1-regulated exosomal EBV-LMP1 empowers endothelial cells with an aggressive phenotype by activating the Akt/ERK pathway in nasopharyngeal carcinoma

CELLULAR ONCOLOGY

IF4.8

2023-03-1410

Identification of Prognosis-Related Oxidative Stress Model with Immunosuppression in HCC

BIOMEDICINES

IF3.9

2023-02-244

OAAI

Dosimetric comparison of two dose expansion methods in intensity modulated radiotherapy for breast cancer

乳腺癌调强放疗两种剂量扩展方法的剂量学比较

RADIATION ONCOLOGY

IF3.2

2023-02-047

OAAI

The miRNA-185-5p/STIM1 Axis Regulates the Invasiveness of Nasopharyngeal Carcinoma Cell Lines by Modulating EGFR Activation-Stimulated Switch from E- to N-Cadherin

miRNA-185-5p/STIM1轴通过调节EGFR激活刺激的从e-cadherin到n-cadherin的转换来调节鼻咽癌细胞系的侵袭力

MOLECULES

IF4.6

2023-01-136

OAAI

Chiral metasurface design with highly efficient and controllable asymmetric transmission and perfect polarization conversion of linearly polarized electromagnetic waves in the THz range

具有高效可控非对称传输和THz范围内线性极化电磁波的完美极化转换的手性超表面设计

JOURNAL OF PHYSICS D-APPLIED PHYSICS

IF3.2

2022-05-0912

PRE

Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2

鲁索替尼通过选择性靶向Janus激酶1/2抑制肝纤维化进展并加速纤维化逆转

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2022-04-0516

OAAI

Epstein-Barr Virus Promotes Tumor Angiogenesis by Activating STIM1-Dependent Ca2+ Signaling in Nasopharyngeal Carcinoma

PATHOGENS

IF3.3

2021-10-0310

OAAI

Yue Luo

个人简介

教育背景

工作经历

荣誉奖项

研究方向